CVS introduces generic rival to EpiPen, private company providing version for free

CVS is now selling a rival generic version of Mylan's EpiPen at about one-sixth of its price, The Associated Press reported Jan. 12.

A week later, Kaléo, a private pharmaceutical company, said in a Jan. 19 news release it would be offering its own version of the injector with $0 out-of-pocket cost for patients with commercial insurance.

The drugstore chain said it will charge $109.99 for a two-pack of the authorized generic version of Adrenaclick. EpiPen can cost more than $600, The AP reported.

CVS Health Corp., the nation's second-largest drugstore chain, said it cut the price of the generic version of Adrenaclick nearly in half.

Kaléo's version, called AUVI-Q, will be available for free to those with a household income of less than $100,000 and do not have government or commercial insurance, the release said. The offer is through the company's access program. The cash price of the injector is $360.

The treatments are used to stop anaphylaxis, an allergic reaction to insect bites and stings and foods like nuts and eggs.
Kelcie Willis with the Cox Media Group National Content Desk contributed to this story.

About the Author